Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum IMV Inc IMVIF

Healthcare Biotechnology
IMV Inc. is a Canada-based company. The Company has no business operations.

Bullboard (GREY:IMVIF)

View:
Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Next
Comment by Breakthorough1on Aug 16, 2023 4:04pm

RE:Third report - Horizon

There are no succesful bids. Because no bid can pay the debt and everything goes to Horizon? "As mentioned in the Second Report, by 5:00 pm (Halifax Time) on July 10, 2023 (the “Bid  ...more  
85
Discussion
Post by Breakthorough1on Aug 16, 2023 3:50pm

Third report - Horizon

"Subsequent to the Bid Deadline, Horizon Technology Finance Corporation (“Horizon”),  notified the Monitor and the IMV Group of its intention to use its secured debt as  ...more  
140
Discussion
Post by Breakthorough1on Aug 16, 2023 8:08am

At the court by friday the 18th

The outcome is very soon: "The Monitor understands that the IMV Group intends to be back before this Honourable  Court by August 18, 2023 for a further update and to seek approval of a ...more  
121
Post by Breakthorough1on Aug 15, 2023 3:15pm

August 11 2022

“Starting with an early look at our VITALIZE data in the third quarter of 2022 and continuing through mid-2023, we expect to communicate results and translational data from all our active clinical ...more  
101
Post by Breakthorough1on Aug 15, 2023 7:29am

March 17th 2021. Another when/will

" Hepatocellular Carcinoma (liver) HCC indication, IMV and its partner Merck have decided to adjust some of the enrollment criteria in order to accelerate enrollment rates. An update will be ...more  
108
Post by Breakthorough1on Aug 14, 2023 3:18pm

16th March - suggesting he knew the "mechanics"?

"Now the exact mechanics and details of what that collaboration is going to be, Joe, I can’t talk to, but these aren’t conversations that we started yesterday. This is an evolution of that. And ...more  
103
Post by Breakthorough1on Aug 14, 2023 10:26am

17 March 2021

"Based on these results, IMV recently engaged with the FDA which provided productive feedback. The Company is working with Merck to finalize the protocol of the Phase 2b clinical study which is ...more  
109
Post by antigua1987on Aug 14, 2023 9:21am

Another ir SOS lands role

disgusting career. what useless types do.
99
Comment by Breakthorough1on Aug 14, 2023 4:13am

RE:From 86% (then 76%) to 46.2% ORR in PDL1+

The OS is very good though: 10,1 months ITT; 17,4 months PDL1+. And with justification of MOA: 24,2 months in those patients with ELISpPlot response tu survivin; 24, 2 months in those with injection ...more  
74
Discussion
Post by Breakthorough1on Aug 14, 2023 12:14am

From 86% (then 76%) to 46.2% ORR in PDL1+

  That's a good drop since the ASH 2020 disclosed data till the 2023 publication of SPiReL results...   https://onlinelibrary.wiley.com/doi/10.1111/ejh.13982
187
Discussion
Comment by Breakthorough1on Aug 13, 2023 7:37am

RE:May 12 2021

Well, not exactly. But the study was "finished" in December 2021 and only bladder data were released (april 2022).
43
Discussion
Post by Breakthorough1on Aug 13, 2023 7:35am

May 12 2021

Again, "will" depending on "when": Maveropepimut-S: Phase 2 Basket Trial in Multiple Advanced Metastatic Solid Tumors Enrollment continues for subjects with metastatic bladder ...more  
110
Discussion
Post by Breakthorough1on Aug 13, 2023 2:54am

Covid timeline (from "concerned shareholder")

"   On March 30, 2020, IMV announced that its goal was ...more  
153
Post by Breakthorough1on Aug 13, 2023 2:47am

July 14th 2020

"Next milestones are anticipated as we commence phase 1 clinical trials this summer with results in the Fall of 2020. Once results are published, we plan to initiate phase 2 clinical trials in ...more  
130
Post by Breakthorough1on Aug 13, 2023 2:44am

October 8th 2020

"In consultation with Health Canada, IMV decided to combine its original Phase 1 and 2 studies into a single trial with the potential to accelerate the clinical development and the timeline of ...more  
155
Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Next
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities